Skip to main content
. 2012 Jun 15;103(8):1489–1492. doi: 10.1111/j.1349-7006.2012.02311.x

Table 2.

Characteristics of patients with advanced pancreatic cancer who participated in this study (= 14)

Age, median (range), years 60 (40–77)
Gender, male/female, n (%) 5 (36)/9 (64)
ECOG performance status 0/1, n (%) 8 (57)/6 (43)
Disease extent, locally advanced/metastatic, n (%) 7 (50)/7 (50)
Site of primary tumor, head/body or tail, n (%) 4 (29)/10 (71)
Site of metastasis, n (%)
Liver 5 (36)
Lung 3 (21)
Lymph node 5 (36)
Peritoneum 2 (14)
CA19‐9, IU/L, median (range) 1909 (17–23 290)